ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

12 links0 made here, not in the record22 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06102824Organoid-based FunctionalPrecision Therapy forAdvanced Breast CancerGuangdong Provincial People's Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSBreast NeoplasmsNo longer in the registry's filing›As of now · Rule based · Main conditionMain conditionDRUGSTaxaneIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorCapecitabineIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorGemcitabineIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorVinorelbineIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorEribulinIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorAnthracyclinesEntry “Anthracycline”, read by our na…›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorCarboplatinIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorDesoxyepothilone BEntry “Utidelone”, read by our name r…›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorTrastuzumab deruxtecanIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorSacituzumab govitecanIntervention entry›Nov 2 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorTrastuzumabIntervention entry›Nov 2 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Taxane

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Taxane”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Comparator
Comparator · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2TaxaneClaude Opus 5.5ComparatorCurrent
Nov 2CapecitabineClaude Opus 5.5ComparatorCurrent
Nov 2GemcitabineClaude Opus 5.5ComparatorCurrent
Nov 2VinorelbineClaude Opus 5.5ComparatorCurrent
Nov 2EribulinClaude Opus 5.5ComparatorCurrent
Nov 2AnthracyclinesClaude Opus 5.5ComparatorCurrent
Nov 2CarboplatinClaude Opus 5.5ComparatorCurrent
Nov 2Desoxyepothilone BClaude Opus 5.5ComparatorCurrent
Nov 2Trastuzumab deruxtecanClaude Opus 5.5ComparatorCurrent
Nov 2Sacituzumab govitecanClaude Opus 5.5ComparatorCurrent
Nov 2TrastuzumabClaude Opus 5.5Not givenCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 18TaxaneRule based · role ruleComparatorAgrees
Nov 18CapecitabineRule based · role ruleComparatorAgrees
Nov 18GemcitabineRule based · role ruleComparatorAgrees
Nov 18VinorelbineRule based · role ruleComparatorAgrees
Nov 18EribulinRule based · role ruleComparatorAgrees
Nov 18AnthracyclinesRule based · role ruleComparatorAgrees
Nov 18CarboplatinRule based · role ruleComparatorAgrees
Nov 18Desoxyepothilone BRule based · role ruleComparatorAgrees
Nov 18Trastuzumab deruxtecanRule based · role ruleComparatorAgrees
Nov 18Sacituzumab govitecanRule based · role ruleComparatorAgrees
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.